secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001628280-23-037159
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q3 revenue $31.9M (+17% YoY), net income up 56%, raises FY 2023 guidance
--------------------------------------------------------------------------------

- Net revenues $31.9M (+17% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M prior year.
- Adjusted EBITDA $6.2M (+11% YoY); FY 2023 net revenue growth guidance raised to >11% (from >10%).
- Patient Services revenue $19.3M (+11%), Device Solutions $12.6M (+27%); gross margin fell to 50.9% from 59.5%.
- Operating income increased 80%; record revenue for seventh consecutive quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/0001628280-23-037159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828023037159/infu-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-037159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer